Alar Pharmaceuticals Inc. (TPEX: 6785)
Taiwan
· Delayed Price · Currency is TWD 183.00
-8.00 (-4.19%)
Sep 10, 2024, 1:30 PM CST
Alar Pharmaceuticals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | 417.67 | 382.62 | -19.87 | -64.23 | -142.8 | -67.97 | Upgrade
|
| Depreciation & Amortization | 3.65 | 3.35 | 3.21 | 3.36 | 2.84 | 3.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 10.52 | Upgrade
|
| Stock-Based Compensation | 0.85 | - | - | - | 0.36 | - | Upgrade
|
| Other Operating Activities | -18.06 | -9.65 | -15.49 | -1.5 | -1.62 | -1.06 | Upgrade
|
| Change in Accounts Receivable | - | 0.84 | -0.84 | - | - | - | Upgrade
|
| Change in Accounts Payable | -0.9 | 18.38 | 0.31 | 0.49 | -0.15 | -8.51 | Upgrade
|
| Change in Unearned Revenue | -152.77 | 1.25 | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 2.25 | 6.79 | -0.26 | -1.6 | -0.56 | -5.58 | Upgrade
|
| Operating Cash Flow | 253.58 | 403.57 | -32.95 | -63.47 | -141.92 | -69.44 | Upgrade
|
| Capital Expenditures | -2.84 | -6.34 | -1.14 | -1.58 | -0.39 | - | Upgrade
|
| Investment in Securities | -1,799 | -125.66 | -30.87 | 22.67 | - | 5.92 | Upgrade
|
| Other Investing Activities | 31.93 | 13.82 | 2.17 | 1.42 | 104.7 | -4.7 | Upgrade
|
| Investing Cash Flow | -1,770 | -118.18 | -29.84 | 22.51 | 104.32 | 1.22 | Upgrade
|
| Long-Term Debt Repaid | - | -1.28 | -0.93 | -0.93 | -0.89 | -0.89 | Upgrade
|
| Net Debt Issued (Repaid) | -1.31 | -1.28 | -0.93 | -0.93 | -0.89 | -0.89 | Upgrade
|
| Issuance of Common Stock | 1,676 | - | - | - | 550 | - | Upgrade
|
| Financing Cash Flow | 1,574 | -1.28 | -0.93 | -0.93 | 549.11 | -0.89 | Upgrade
|
| Net Cash Flow | 57.82 | 284.11 | -63.71 | -41.89 | 511.5 | -69.1 | Upgrade
|
| Free Cash Flow | 250.74 | 397.23 | -34.09 | -65.05 | -142.31 | -69.44 | Upgrade
|
| Free Cash Flow Margin | 53.43% | 84.65% | -4260.75% | - | -23717.83% | - | Upgrade
|
| Free Cash Flow Per Share | 4.09 | 6.96 | -0.60 | -1.14 | -2.85 | -1.98 | Upgrade
|
| Cash Interest Paid | 0.04 | 0.06 | 0.02 | 0.02 | 0.03 | 0.04 | Upgrade
|
| Cash Income Tax Paid | 5.19 | 1.23 | 0.04 | - | - | - | Upgrade
|
| Levered Free Cash Flow | 120.97 | 311.67 | -28.45 | -35.15 | -121.22 | -52.64 | Upgrade
|
| Unlevered Free Cash Flow | 121 | 311.71 | -28.43 | -35.13 | -121.2 | -52.61 | Upgrade
|
| Change in Net Working Capital | 119.4 | -73.74 | 1.42 | -21.39 | 17.29 | 17.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.